Gemphire Therapeutics - Daily Chart

Name
*Data as of: 2017-08-17
Company Summary DEVELOPS THERAPIES TO TREAT DYSLIPIDEMIA, A MEDICAL CONDITIO N THAT INCREASES THE RISK OF CARDIOVASCULAR DISEASE.
Daily Stock Data   Dates and Ratios   Company Background
Symbol GEMP Earnings Date 2017-11-03 Exchange NASDAQ
Name Gemphire Therapeutics Ex Dividend Date N/A Sector Medical
Close $8.60 Exp. Dividend Amount N/A Industry Medical - Biomed / Biotech
$ Change
+0.07
Dividend Yield 0.00 Market Cap 91M
% Change
+0.80%
Alpha 0.03 Enterprise Value 61M
Open 8.57 Beta 1.03 Shares 1000s 10,600
Days Range 8.47 - 8.74 Daily ATR 1.69 Incorp Date 2014
52 Week Range 7.20 - 21.59 Daily ATR% 19.66% IPO Date 2016-08-05
Volume 91,400 Price/Earnings 0.00 Location MT 48152,MT
Avg Vol 50d 159,488 Price/Book 4.42 ADR No
Vol % Chg vs 50 Day
-42.30%
Price/Sales 0.00 Options No
Up/Down Volume 1.00 PEG 0.00 ETF/Closed End Fund No
AD Rating Timeliness Rating Industry Group Rank
Symbol Comp Rating EPS Rating SMR Rating RS Rating Sponsor Rating Current Last Week Current Last Week Ind Group RS Current Last Week 3 Months Ago 6 Months Ago Industry Group Sector
GEMP 13 2 16 C- D E E A+ 7 7 32 40 Medical-Biomed/Biotech MEDICAL
   
Stock Symbol   Sector   Industry Group
GEMP   Medical   Medical - Biomed / Biotech
Overall Stock Ratings   Stock Ratings within Sector   Stock Ratings within Industry
Full 42.28 Full 46.5051 Full 51.48
Earnings 0.17 Earnings 0.76 Earnings 1.37
Sales 33.06 Sales 27.57 Sales 24.60
Margins 12.43 Margins 28.72 Margins 33.94
Valuation 71.83 Valuation 59.59 Valuation 51.71
Best Rated Stocks Overall   Best Rated Stocks in Sector:
Medical
  Best Rated Stocks in Industry:
Medical - Biomed / Biotech
JP 100.00 CORT 100.00 CORT 100.00
ESNT 99.98 LMAT 99.87 BIVV 99.77
FB 99.96 ABMD 99.75 CELG 99.54
ANET 99.94 FONR 99.62 SUPN 99.32
YY 99.92 ALGN 99.49 REGN 99.09
*All ratings range from 0 to 100 with 100 being the highest.
 
Stock Symbol   Sector   Industry Group
GEMP   Medical   Medical - Biomed / Biotech
% Gain   Average Stock Gain % in Sector   Average Stock Gain % in Industry
1 Day
+0.80%
1 Day
-1.21%
1 Day
-1.97%
1 Week
+6.70%
1 Week
+0.31%
1 Week
+0.31%
2 Weeks
-56.07%
2 Weeks
-1.48%
2 Weeks
-2.36%
3 Weeks
-57.45%
3 Weeks
-1.56%
3 Weeks
-3.33%
1 Month
-48.50%
1 Month
-2.75%
1 Month
-3.39%
3 Months
-17.47%
3 Months
+4.62%
3 Months
+10.11%
6 Months
-14.17%
6 Months
+10.17%
6 Months
+12.42%
1 year
-15.02%
1 year
+10.61%
1 year
+17.35%
YTD
+9.69%
YTD
+18.43%
YTD
+27.43%
 
Sector Info   Sector Ranking   Average Stock Gain % in Sector
Symbol GEMP Current 17 1 Day
-1.21%
Sector Medical Yesterday 16 1 Week
+0.31%
Market Val(Bil) 4,235.49B 1 Week Ago 18 2 Weeks
-1.48%
Industry Groups 391 2 Week Ago 15 3 Week
-1.56%
Total Stocks 703 3 Week Ago 9 1 Month
-2.75%
New Highs 10 1 Month Ago 13 3 Month
+4.62%
New Highs % 1.42% 3 Month Ago 23 6 Months
+10.17%
New Lows 32 6 Month Ago 30 1 year
+10.61%
New Lows % 4.55% 1 Year Ago 22 YTD
+18.43%
 
Industry Group Info   Industry Group Ranking   Average Stock Gain % in Industry
Symbol GEMP Current 47 1 Day
-1.97%
Industry Group Medical - Biomed / Biotech Yesterday 35 1 Week
+0.31%
Market Val(Bil) 794.93B 1 Week Ago 34 2 Weeks
-2.36%
Total Stocks 391 2 Weeks Ago 29 3 Weeks
-3.33%
New Highs 3 3 Weeks Ago 16 1 Month
-3.39%
New Highs % 0.77% 1 Month Ago 39 3 Months
+10.11%
New Lows 21 3 Months Ago 142 6 Months
+12.42%
New Lows % 5.37% 6 Months Ago 123 1 Year
+17.35%
      1 Year Ago 132 YTD
+27.43%
Data as of: 2017-08-17
Daily Stock Data   Dates and Ratios   Company Background
Symbol GEMP Earnings Date 2017-11-03 Exchange NASDAQ
Name Gemphire Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 8.6 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.07 Dividend Yield 0 Market_Cap_mil 91.2
% Change 0.8 Alpha 0.03 Enterprise_Val_mil 61.1
Open 8.57 Beta 1.03 Shares_1000s 10600
Day's Range 8.47 - 8.74 Daily ATR 1.69 Incorp_Date 2014
52 Week Range 7.2 - 21.59 Daily ATR% 19.66 IPO Date 2016-08-05
Volume 9,140,000 Price/Earnings Location MT 48152,MT
Avg Vol 50d 15,948,800 Price/Book 4.42 ADR No
Short Volume 248,290 Price/Sales Options No
Shrt Int Pcnt Chg -33.3 PEG ETF/Closed End Fund No
Data as of: 2017-08-17
Daily Stock Data   Dates and Ratios   Company Background
Symbol GEMP Earnings Date 2017-11-03 Exchange NASDAQ
Name Gemphire Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 8.6 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.07 Dividend Yield 0 Market_Cap_mil 91.2
% Change 0.8 Alpha 0.03 Enterprise_Val_mil 61.1
Open 8.57 Beta 1.03 Shares_1000s 10600
Day's Range 8.47 - 8.74 Daily ATR 1.69 Incorp_Date 2014
52 Week Range 7.2 - 21.59 Daily ATR% 19.66 IPO Date 2016-08-05
Volume 9,140,000 Price/Earnings Location MT 48152,MT
Avg Vol 50d 15,948,800 Price/Book 4.42 ADR No
Short Volume 248,290 Price/Sales Options No
Shrt Int Pcnt Chg -33.3 PEG ETF/Closed End Fund No
Sales Ratings (0 to 10) Sales Accelerating % Sales Growth % Sales Growth Rank
Symbol Overall within Sector within Industry Annual Sales 2Q 3Q Last Qtr Last Yr 3 Years 5 Years Last Qtr Last Yr 3 Years 5 Years
GEMP 33.06 27.57 24.6 0M No No
Data as of: 2017-08-17
Daily Stock Data   Dates and Ratios   Company Background
Symbol GEMP Earnings Date 2017-11-03 Exchange NASDAQ
Name Gemphire Therapeutics Ex Dividend Date N/A Sector MEDICAL
Close 8.6 Exp. Dividend Amt N/A Industry Medical-Biomed/Biotech
$ Change 0.07 Dividend Yield 0 Market_Cap_mil 91.2
% Change 0.8 Alpha 0.03 Enterprise_Val_mil 61.1
Open 8.57 Beta 1.03 Shares_1000s 10600
Day's Range 8.47 - 8.74 Daily ATR 1.69 Incorp_Date 2014
52 Week Range 7.2 - 21.59 Daily ATR% 19.66 IPO Date 2016-08-05
Volume 9,140,000 Price/Earnings Location MT 48152,MT
Avg Vol 50d 15,948,800 Price/Book 4.42 ADR No
Short Volume 248,290 Price/Sales Options No
Shrt Int Pcnt Chg -33.3 PEG ETF/Closed End Fund No
Margins Ratings (0 to 10) Average After Tax Margins
Symbol Overall within Sector within Industry Pretax Margin Last Qtr After Tax Margin Accel 3Q After Tax Margin Last Qtr 2 Qtr 3 Qtr 4 Qtr 5 Qtr 6 Qtr
GEMP 12.43 28.72 33.94 No
 
Stock Symbol   Sector   Industry Group
GEMP   Medical   Medical - Biomed / Biotech
Ratios   Average Ratios in Sector   Average Ratios in Industry
Price/Earnings (PE) 0.00 Price/Earnings (PE) 48.47 Price/Earnings (PE) 99.02
Price/Book (PB) 4.42 Price/Book (PB) 1.39 Price/Book (PB) 2.91
Price/Sales (PS) 0.00 Price/Sales (PS) 188.99 Price/Sales (PS) 380.37
Price/Cash Flow (PCF) -8.26 Price/Cash Flow (PCF) 0.82 Price/Cash Flow (PCF) -8.49
PEG 0.00 PEG 2.57 PEG 0.68
Dividend Adj PEG 0.00 Dividend Adj PEG 2.28 Dividend Adj PEG 0.67
Return on Equity (ROE) -353.50 Return on Equity (ROE) -94.28 Return on Equity (ROE) -127.50
Yield 0.00 Yield 1.12 Yield 1.69
Current Ratio 6.57 Current Ratio 5.64 Current Ratio 7.40
Debt % 0.00% Debt % 86.33% Debt % 43.18%
Long Term Debt/Work Capital 0.00 Long Term Debt/Work Capital -0.91 Long Term Debt/Work Capital 0.20
 
Stock GEMP   Exponential Moving Averages   Simple Moving Averages
Name Gemphire Therapeutics EMA 10 days
10.33(-16.75%)
SMA 10 days
9.70(-11.34%)
Close $8.60 EMA 20 days
12.35(-30.36%)
SMA 20 days
14.57(-40.97%)
$ Change
+0.07
EMA 50 days
13.15(-34.6%)
SMA 50 days
13.58(-36.67%)
% Change
+0.80%
EMA 89 days
12.62(-31.85%)
SMA 79 days
12.51(-31.25%)
Volume 91,400 EMA 100 days
12.47(-31.03%)
SMA 100 days
12.19(-29.45%)
Avg Volume 159,488 EMA 200 days
11.52(-25.35%)
SMA 200 days
10.86(-20.81%)
Vol% vs. Avg Vol
-42.30%
           
Up/Down Vol 1.00   Keltner Channel   Bollinger Band
Distribution Days 5   Upper
13.97(-38.44%)
  Upper
25.30(-66.01%)
ATR 1.69   Mid
11.77(-26.93%)
  Mid
14.57(-40.97%)
ATR% 19.66%   Lower
9.57(-10.14%)
  Lower
3.85(123.38%)